跳至主要内容
临床试验/ISRCTN18278231
ISRCTN18278231进行中(未招募)3 期

Clinical trial of a melatonin-pregabalin combination for fibromyalgia

Canadian Institutes of Health Research0 个研究点目标入组 54 人开始时间: 2024年4月2日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
入组人数
54

研究概览

简要总结

2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38910006/ (added 25/06/2024)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Participants =18 years old and over meeting the 2016 American College of Rheumatology diagnostic criteria for fibromyalgia
  • 2. Daily moderate pain (= 3/10) for at least 3 months
  • 3. Liver function test, ALT, no greater than 20% above normal
  • 4. Creatinine clearance >50 mL/min
  • 5. Sufficient cognitive function and language comprehension skills – regardless of native language – for questionnaire completion and communication with trial personnel (and translator, if necessary)
  • 6. Women of childbearing potential will be required to receive a highly effective form of contraception

排除标准

  • 1. Participants with any major organ system disease, psychiatric, suicidal ideation or substance abuse disorder, which, in the opinion of the investigators, would interfere with trial participation
  • 2. Hypersensitivity to any of the study medications
  • 3. Other painful conditions as severe as fibromyalgia pain
  • 4. Shift workers who work during typical sleeping hours
  • 5. Any other abnormalities or conditions that, in the judgement of the investigators would interfere with the protocol

研究者

相似试验

The PRECISE trial – Pain RElief Combination... | 临床试验